Skip to main content

Cancer Moonshot Scholars Diversity Program (CMSDP)

NCI - Equity and Inclusion Program graphic

The Cancer Moonshot Scholars Diversity Program (CMSDP) seeks to increase the number of Early-Stage Investigators (ESIs) from groups identified as underrepresented (URGs) in the biomedical, clinical, behavioral, and social sciences research workforce, while promoting scientific advancements through the diversification of NCI’s investigator pool. The program aims to enhance the number of applications submitted by and awards made to ESIs from URGs, and to increase diversity of thought and approach to cancer research. NCI intends to fund a minimum of 45 new R01s through the CMSDP over the next three years.

CMSDP has not yet issued any Funding Opportunity Announcements (FOAs). Please continue to check this page for FOA information and additional resources.

This program is supported by the White House's Cancer Moonshot initiative and NCI. CMSDP will be led by NCI’s Center to Reduce Cancer Health Disparities, with trans-NCI input and participation from a Steering Committee that includes the Division of Cancer Biology, Division of Cancer Control and Population Sciences, Division of Cancer Prevention, Division of Cancer Treatment and Diagnosis, Center for Cancer Training, and Center for Research Strategy.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot Scholars Diversity Program (CMSDP) was originally published by the National Cancer Institute.”